Citi Reiterates Hold and Pt of $35 on Forest Laboratories

Citi reiterated its Hold rating on Forest Laboratories FRX. At the same time, the rating agency left its price target on the company's stock unchanged at $35 ahead of the company's Q2 earnings report, which is due on July 19th. On Tuesday, FRX lost 0.23% of its value to finish the day at $38.61.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: ReiterationAnalyst RatingsCitiHealth CarePharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!